Lnc-OXAR has a pivotal role in OXA resistance of NASH-HCC by enhancing Ku70 stability to protect cancer cells from double-strand DNA breaks (DSBs). Here, XRCC6 is linked to metabolic dysfunction-associated steatohepatitis.